--- title: "潤本生物技術股份有限公司 (603193.SH)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/603193.SH.md" symbol: "603193.SH" name: "潤本生物技術股份有限公司" industry: "個人護理產品" --- # 潤本生物技術股份有限公司 (603193.SH) | Item | Detail | |------|--------| | Industry | 個人護理產品 | | Location | 滬深市場 | | Website | [www.runben.com](https://www.runben.com) | ## Company Profile 公司是創造健康生活方式的高新技術企業。公司創立于 2006 年,集專業研發、生產和銷售為一體,專注于驅蚊、個人護理等領域,是國內知名驅蚊及個人護理用品公司。公司主要從事個人護理類、驅蚊類產品的研發、生產和銷售。公司主要產品為嬰童護理產品、驅蚊產品、精油產品三大核心產品系列。 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-23T04:30:12.000Z **Overall: B (0.24)** **Industry**: Personal Care Products | Metric | Value | |--------|-------| | Industry Ranking | 5 / 27 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 21.75% | | | Net Profit YoY | -0.28% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 4.33 | | | Dividend Ratio | 1.85% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 9.40B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 1.52B | | **Multi Score**: B #### Profit Score: A | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 14.49% | A | | Profit Margin | 20.11% | A | | Gross Margin | 59.64% | A | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 21.75% | A | | Net Profit YoY | -0.28% | C | | Total Assets YoY | 3.97% | C | | Net Assets YoY | 6.44% | B | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 497.24% | C | | OCF YoY | 21.75% | A | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.67 | B | #### Debt Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 5.81% | A | ```chart-data:radar { "title": "Longbridge Financial Score - 潤本生物技術股份有限公司", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "A", "indicators": [ { "name": "ROE", "value": "14.49%", "rating": "A" }, { "name": "Profit Margin", "value": "20.11%", "rating": "A" }, { "name": "Gross Margin", "value": "59.64%", "rating": "A" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "21.75%", "rating": "A" }, { "name": "Net Profit YoY", "value": "-0.28%", "rating": "C" }, { "name": "Total Assets YoY", "value": "3.97%", "rating": "C" }, { "name": "Net Assets YoY", "value": "6.44%", "rating": "B" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "497.24%", "rating": "C" }, { "name": "OCF YoY", "value": "21.75%", "rating": "A" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.67", "rating": "B" } ] }, { "name": "Security", "grade": "A", "indicators": [ { "name": "Gearing Ratio", "value": "5.81%", "rating": "A" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 珀萊雅 (SH.603605) | A | C | A | B | C | B | | 02 | 飛科電器 (SH.603868) | B | D | A | A | C | B | | 03 | 丸美生物 (SH.603983) | B | B | B | B | B | B | | 04 | 天新藥業 (SH.603235) | B | B | C | A | C | B | | 05 | 潤本股份 (SH.603193) | A | B | B | A | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 30.78 | 8/28 | 45.22 | 38.64 | 33.10 | | PB | 4.33 | 19/28 | 6.77 | 5.53 | 4.65 | | PS (TTM) | 6.19 | 24/28 | 10.86 | 8.34 | 6.66 | | Dividend Yield | 1.85% | 8/28 | 1.78% | 1.39% | 1.04% | ## Institutional View ### Analyst Rating Distribution > As of 2026-01-21T16:00:00.000Z Total Analysts: **3** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 2 | 67% | | Overweight | 1 | 33% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 23.23 | | Highest Target | 36.40 | | Lowest Target | 32.54 | ## References - [Company Overview](https://longbridge.com/en/quote/603193.SH/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/603193.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/603193.SH/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.